I
Investigacion Biomedica para el Desarrollo de Farmacos, S.A. de C.V. | Zapopan, Mexico
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Risankizumab
Ezabenlimab
BI 765179
Cetuximab
BI 765063
BI 836880
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 5 total trials
The study consists of 4 sub-studies, as follows:* Sub-study 1 (Randomized, double-blind, placebo controlled study) to evaluate the efficacy and safet...
Active, not recruiting
Crohn's Disease
Drug: Placebo for Risankizumab IV
Drug: Risankizumab SC
This study is open to adults with advanced cancer (solid tumors) and people with advanced head and neck cancer. The study has 2 parts. The purpose of...
Enrolling
Neoplasms
Drug: Ezabenlimab
Drug: BI 765179
With an amendment of the protocol, this study is only open to adults with head and neck cancer. Previously also adults with liver cancer joined. This...
Active, not recruiting
Head and Neck Squamous Cell Carcinoma (HNSCC)
Drug: Cetuximab
Drug: Ezabenlimab
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems